These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. To stop or not? Mets B Anesth Analg; 2015 Jun; 120(6):1413-9. PubMed ID: 25988640 [No Abstract] [Full Text] [Related]
24. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age. Schaefer F; van de Walle J; Zurowska A; Gimpel C; van Hoeck K; Drozdz D; Montini G; Bagdasorova IV; Sorof J; Sugg J; Teng R; Hainer JW; J Hypertens; 2010 May; 28(5):1083-90. PubMed ID: 20160654 [TBL] [Abstract][Full Text] [Related]
25. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy]. Ovchinnikov AG; Serbul VM; Ageev FT Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590 [TBL] [Abstract][Full Text] [Related]
26. [AT 1-blocker can be given in addition to ACE inhibitor and beta blocker. "Triple therapy decidedly well tolerated even in severe heart failure"]. Dietz R MMW Fortschr Med; 2004 May; 146(22):50. PubMed ID: 15373115 [No Abstract] [Full Text] [Related]
27. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)]. Mann J Internist (Berl); 2007 Apr; 48(4):436-8. PubMed ID: 17342351 [No Abstract] [Full Text] [Related]
29. The VALUE trial: a commentary. Sever P J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243 [TBL] [Abstract][Full Text] [Related]
30. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury. Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373 [TBL] [Abstract][Full Text] [Related]
31. Choice of treatment: outcomes and treatment goals. Temple RJ Am Heart J; 2003 Oct; 146(4):565-7. PubMed ID: 14564306 [No Abstract] [Full Text] [Related]
32. [Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension]. Minami J; Ishimitsu T; Matsuoka H Nihon Jinzo Gakkai Shi; 2005; 47(8):864-9. PubMed ID: 16408430 [TBL] [Abstract][Full Text] [Related]
33. [Contemporary pharmacotherapy of arterial hypertension in medical personnel]. Bakumov PA; Zerniukova EA; Grechkina ER Med Tr Prom Ekol; 2012; (6):42-4. PubMed ID: 22997759 [TBL] [Abstract][Full Text] [Related]
34. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related]
35. From TROPHY with pride. Julius S; Schork A; Egan BM Am J Hypertens; 2007 Mar; 20(3):342-3; author reply 343-5. PubMed ID: 17324750 [No Abstract] [Full Text] [Related]
36. Administration time difference of candesartin effect on albuminuria in type 2 diabetic patients. Shimizu H; Uehara Y; Ohsaki A; Okada S; Mori M Hypertens Res; 2009 Jun; 32(6):527-8. PubMed ID: 19373237 [No Abstract] [Full Text] [Related]